Aptevo Therapeutics Inc. (APVO) Declined -5.39% or -0.18 To Price $3.16 On Wednesday


Aptevo Therapeutics Inc. (APVO) declined -5.39% or -0.18 to $3.16. It is about 98648 shares traded, which is 50.27% compare to the average total volume 196219. The market cap of APVO is $67.71 million. The year to date change is -29.68%. The 52 week price range is from $1.15 to $4.85. Price of APVO have changed 6.37% during last week. It have changed -0.89% over last month, 12.46% over last 3 months, 180.67% over last 6 months and 61.35% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for APVO is 3.72. It is 17.72% above current price. The 200-day Moving Averages for APVO is 2.60. It is -17.72% below current price. The 52-week High is 4.85. It is 53.48% from the current price. The 52-week Low is 1.15. It is -63.61% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of APVO is 1.03 on 2018-01-31. Short % to float is 1.41%. There are some statistics of APVO. It is has market cap $67.71 million. The share outstanding is 21.43 million. The average volume is 196219. The revenue is 53.58M. The gross profit is 28.52M. The percent of top 15 Institution holding is 39.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of APVO is 2.28%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of APVO is 1.51%.


Tags:

Share this post